Deborah Sheldon, APRN
Gerontology · Kearney, NENPI 1649538448
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations.
Across 74 payments — averaging $21.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aimmune Therapeutics, Inc.$259
- Takeda Pharmaceuticals U.S.A., Inc.$161
- Fresenius USA Marketing, Inc.$140
- Argenx US, Inc.$87
- AbbVie$74
- AstraZeneca$73
- plus $780 from 24 others
What the payments were for
- Food & beverage$1,574100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aimmune Therapeutics, Inc. | 2 | $259 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $161 |
| Fresenius USA Marketing, Inc. | 8 | $140 |
| Argenx US, Inc. | 3 | $87 |
| AbbVie | 4 | $74 |
| AstraZeneca(2 entities) | 5 | $73 |
| Neurocrine Biosciences, Inc. | 4 | $70 |
| Amgen | 4 | $65 |
| Lilly USA, LLC | 4 | $63 |
| Bayer | 3 | $63 |
| Mallinckrodt Hospital Products Inc. | 2 | $60 |
| Genentech USA, Inc. | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| CSL Behring | 2 | $37 |
| Travere Therapeutics, Inc. | 3 | $35 |
| Vifor Pharma, Inc. | 2 | $34 |
| Grifols USA, LLC | 2 | $33 |
| Johnson & Johnson | 2 | $32 |
| Gilead | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Averitas Pharma Inc. | 1 | $17 |
| Acorda Therapeutics, Inc | 1 | $16 |
| Baxter Healthcare | 1 | $15 |
| Novo Nordisk | 1 | $15 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Merck | 1 | $13 |
| Neurelis, Inc. | 1 | $13 |
| Boehringer Ingelheim | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZENPEP$159
How this compares
$1,574 in reported general payments places this provider in the 80th percentile of 21 gerontology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gerontology in Kearney
- Amy StumpKearney$990
- April SmithLincoln$4K
- Jean SuehlNorfolk$3K
- Jenny DankertOmaha$3K
- Tara PetersonOmaha$2K
- Irish MillsOmaha$670
- Michelle SchielGrand Island$663
- Alexis CushmanOmaha$555
- Marie BissellLincoln$510
- Melissa BowenLincoln$338
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.